×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARTV – artiva biotherapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARTV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
07:56 am
artv
Artiva Biotherapeutics (NASDAQ:ARTV) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Medium
Report
Artiva Biotherapeutics (NASDAQ:ARTV) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
11/12
02:21 pm
artv
Artiva Biotherapeutics (NASDAQ:ARTV) had its price target raised by analysts at HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
Medium
Report
Artiva Biotherapeutics (NASDAQ:ARTV) had its price target raised by analysts at HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
11/12
10:31 am
artv
Artiva Biotherapeutics GAAP EPS of -$0.88 [Seeking Alpha]
High
Report
Artiva Biotherapeutics GAAP EPS of -$0.88 [Seeking Alpha]
11/12
08:21 am
artv
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease [Yahoo! Finance]
Medium
Report
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease [Yahoo! Finance]
11/12
07:20 am
artv
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
High
Report
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
11/12
07:00 am
artv
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
High
Report
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
11/3
04:05 pm
artv
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
Medium
Report
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
10/30
06:27 pm
artv
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/17
08:39 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Horan Christopher
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Horan Christopher
11/17
08:39 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Raymon Heather
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Raymon Heather
11/17
08:39 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Bush Jennifer
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Bush Jennifer
11/17
08:38 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Aslan Fred
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Aslan Fred
11/17
08:38 pm
artv
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Krishnamohan Neha
High
Report
Form 4 Artiva Biotherapeutics, For: Nov 15 Filed by: Krishnamohan Neha
11/17
04:30 pm
artv
Form 144 Artiva Biotherapeutics, Filed by: Aslan Fred
High
Report
Form 144 Artiva Biotherapeutics, Filed by: Aslan Fred
11/12
07:22 am
artv
Form 8-K Artiva Biotherapeutics, For: Nov 12
Medium
Report
Form 8-K Artiva Biotherapeutics, For: Nov 12
11/12
07:08 am
artv
Form 10-Q Artiva Biotherapeutics, For: Sep 30
High
Report
Form 10-Q Artiva Biotherapeutics, For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: